The fourth Roundtable of Longevity Clinics, convening at the Buck Institute in October, shifts its agenda from whether longevity medicine needs shared standards to why so few have materialized. Program sessions focus on diagnostics that measurably alter clinical decisions, AI positioned to support rather than replace clinical judgement, and the tension between clinical defensibility and commercial sustainability as clinic models expand into hospitality, employer benefits and wellness destinations.
Key Points
- Field has moved past debating standards to questioning their absence
- Diagnostics scrutinized for decision impact, not report decoration
- Clinic definitions blurring as hospitality and employer models expand
Longevity Analysis
The value of any longevity intervention depends on whether the measurements behind it genuinely inform a decision. A diagnostic panel that produces impressive documentation but no change in clinical direction adds cost and noise rather than signal, and the same applies to AI layered onto a workflow for presentation rather than judgement. As clinic models extend into hospitality and employer benefits, the discriminating question for practitioners and patients alike becomes whether a given program is structured to interpret the body accurately and sustain intervention over years, or simply to deliver an experience.
Original published by Longevity.Technology, by Eleanor Garth.